Publication Cover
Mitochondrial DNA Part A
DNA Mapping, Sequencing, and Analysis
Volume 30, 2019 - Issue 3
164
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Implementing a new variant load model to investigate the role of mtDNA in oxidative stress and inflammation in a bi-ethnic cohort: the SABPA study

ORCID Icon, , &
Pages 440-447 | Received 30 Jun 2018, Accepted 31 Oct 2018, Published online: 18 Jan 2019

References

  • Achilli A, Olivieri A, Pala M, Hooshiar Kashani BCV, Perego UA, Gandini F, Santoro A, Battaglia V, Grugni V, Lancioni H, et al. 2011. Mitochondrial DNA backgrounds might modulate diabetes complications rather than T2DM as a whole. PloSone 6:e21029.
  • Ashar F, Zhang Y, Longchamps R, Lane J, Moes A, Grove M, Mychaleckyj J, Taylor K, Coresh J, Rotter J, et al. 2017. Association of mitochondrial DNA copy number with cardiovascular disease. JAMA Cardiol. 2:1247–1255.
  • Czajka A, Ajaz S, Gnudi L, Parsade C, Jones P, Reid F, Malik A. 2015. Altered mitochondrial function, mitochondrial DNA and reduced metabolic flexibility in patients with diabetic nephropathy. EBioMedicine 2:499–512.
  • Elson JL, Herrnstadt C, Preston G, Thal L, Morris CM, Edwardson JA, Beal MF, Turnbull DM, Howell N. 2006. Does the mitochondrial genome play a role in the etiology of Alzheimer's disease?. Hum Genet. 119:241–254.
  • Elson JL, Lightowlers R. 2006. Mitochondrial DNA clonality in the dock: can surveillance swing the case?. Trends Genet 22:603–607.
  • Guyatt A, Burrows K, Guthrie P, Ring S, McArdle W, Day I, Ascione R, Lawlor D, Gaunt T, Rodriguez S. 2018. Cardiometabolic phenotypes and mitochondrial DNA copy number in two cohorts of UK women. Mitochondrion 39:9–19.
  • Hamer M, von Känel R, Reimann M, Malan NT, Schutte AE, Huisman HW, Malan L. 2015. Progression of cardiovascular risk factors in black Africans: 3 year follow up of the SABPA cohort study. Atherosclerosis 238:52–54.
  • Harrison DG, Gongora MC, Guzik TJ, Widder J. 2007. Oxidative stress and hypertension. J Am Soc Hypertens 1:30–44.
  • Hayashi I, Morishita Y, Imai K, Nakamura M, Nakachi K, Hayashi T. 2007. High-throughput spectrophotometric assay of reactive oxygen species in serum. Mut Res 631:55–61.
  • Hu C, Wu M, Chao M, Pan C, Wang C, Swenberg J, Wu K. 2004. Comparison of analyses of urinary 8-hydroxy-2’- deoxyguanosine by isotope-dilution liquid chromatography with electrospray tandem mass spectrometry and by enzymelinked immunosorbent assay. Rapid Commun Mass Spectrom 18:505–510.
  • Janero D. 1990. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 9:515–540.
  • Jansen van Vuren E, Malan L, Cockeran M, Scheepers J, Oosthuizen W, Malan N. 2016. Fibrosis and coronary perfusion – a cardiovascular disease risk in an African male cohort: The SABPA study. Clin Exp Hypertens 38:482–488.
  • Jansen van Vuren E, Malan L, von Känel R, Cockeran M, Malan N. 2016. Hyperpulsatile pressure, systemic inflammation and cardiac stress are associated with cardiac wall remodeling in an African male cohort: the SABPA study. Hypertension Res. 39:648–653.
  • Kruger R, Schutte R, Huisman H, Rooyen JV, Malan N, Fourie C, Louw R, Westhuizen F, Deventer C, Malan L, et al. 2012. Associations between reactive oxygen species, blood pressure and arterial stiffness in black South Africans: the SABPA study. J Hum Hypertension 26:91–97.
  • Lee H, Song J, Shin C, Park D, Park K, Lee K, Koh C. 1998. Decreased mitochondrial DNA content in peripheral blood precedes the development of non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 42:161–167.
  • Lee JE, Park H, Ju YS, Kwak M, Kim JI, Oh HY, Seo JS. 2009. Higher mitochondrial DNA copy number is associated with lower prevalence of microalbuminuria. Exp Mol Med. 41:253–258.
  • Liu X, Kim C, Yang J, Jemmerson R, Wang X. 1996. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86:147–157.
  • Malan L, Hamer M, Frasure-Smith N, Steyn HS, Malan NT. 2015. Cohort profile: sympathetic activity and ambulatory blood pressure in Africans (SABPA) prospective cohort study. Int J Epidemiol. 44:1814–1822.
  • Malan L, Malan NT. Emotional stress as a risk for hypertension in sub-Saharan Africans: are we ignoring the odds? In: Islam EMS, editor. Hypertension: from basic research to clinical practice. Advances in experimental medicine and biology. Cham: Spring; 2017. p. 2:497–510.
  • Malik A, Parsade C, Ajaz S, Crosby-Nwaobi R, Gnudi L, Czajka A, Sivaprasad S. 2015. Altered circulating mitochondrial DNA in and increased inflammation in patients with diabetic retinopathy. Diabetic Res Clin Practice. 110:257–265.
  • Mels C, Schutte A, Schutte R, Pretorius P, Smith W, Huisman H, van der Westhuizen F, Fourie C, van Rooyen J, Kruger R, et al. 2014. 8-Oxo-7,8-dihydro-2’-deoxyguanosine, reactive oxygen species and ambulatory blood pressure in African and Caucasian men: the SABPA study. Free Radic Res. 48:1291–1299.
  • Mensah GA. 2013. Descriptive epidemiology of cardiovascular risk factors and diabetes in sub-Saharan Africa. Prog Cardiovasc Dis 56:240–250.
  • Mokhaneli M, Fourie C, Botha S, Mels C. 2016. The association of oxidative stress with arterial compliance and vascular resistance in a bi-ethnic population: the SABPA study. Free Radic Res 50:920–928.
  • Mosteller R. 1987. Simplified calculation of body-surface area. N Engl J Med. 317:1098.
  • Nunnari J, Suomalainen A. 2012. Mitochondria: in sickness and in health. Cell. 148:1145–1159.
  • Oka T, Hikoso S, Yamaguchi O, Taneike M, Takeda T, Tamai T, Oyabu J, Murakawa T, Nakayama H, Nishida K, et al. 2012. Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature 485:251–255.
  • Omboni S, Aristizabal D, De la Sierra A, Dolan E, Head G, Kahan T, Kantola I, Kario K, Kawecka-Jaszcz K, Malan L, et al. 2016. Hypertension types defined by clinic and ambulatory blood pressure in 14 143 patients referred to hypertension clinics worldwide. Data from the ARTEMIS study. J Hypertens 34:2187–2198.
  • Pepys M, Hirschfield G. 2003. C-reactive protein: a critical update. J Clin Investig. 111:1805–1812.
  • Pereira L, Soares P, Radivoiac P, Li B, Samuels DC. 2011. Comparing phylogeny and the predicted pathogenicity of protein variations reveals equal purifying selection across the global human mtDNA diversity. Am J Hum Genet. 8;88:433–439.
  • Pienaar IS, Howell N, Elson JL. 2017. MutPred mutational load analysis shows mildly deleterious mitochondrial DNA variants are not more prevalent in Alzheimer's patients, but may be under-represented in healthy older individuals. Mitochondrion. 34:141–146.
  • Piepoli M, Hoes A, Agewall S, Albus C, Brotons C, Catapano A, Cooney MT, Corra U, Cosyns B, Deaton C, et al. 2016. European guidelines on cardiovascular disease prevention in clinical practice. The Sixth Joint Force of the European Society of Cardiology and other Societies on cardiovascular diasease prevention in clinical practice. Eur Heart J. 5:1–78.
  • Reimann M, Hamer M, Malan N, Schlaich M, Lambert G, Ziemssen T, Boeger R, Malan L. 2013. Effects of acute and chronic stress on the L-arginine nitric oxide pathway in black and white South Africans: the sympathetic activity and ambulatory blood pressure in Africans study. Psychosom Med. 75:751–758.
  • Salas A, Elson JL. 2015. Mitochondrial DNA as a risk factor for false positives in case-control association studies. J Genet Genomi. 42:169–172.
  • Samuels DC, Carothers AD, Horton R, Chinnery PF. 2006. The power to detect disease associated with mitochondrial DNA haplogroups. Am J Hum Genet. 78:713–720.
  • Sandhir R, Halder A, Sunkaria A. 2016. Mitochondria as an entrally positioned hub in the innate immune response. Biochim Biophys Acta. 863:1090–1097.
  • Saude E, Adamko D, Rowe B, Marrie T, Sykes B. 2007. Variation of metabolites in normal human urine. Metabolomics. 3:439–451.
  • Schwedhelm E, Tan-Andresen J, Maas R, Riederer U, Schulze F, Böger R. 2005. Liquid chromatography-tandem mass spectrometry method for the analysis of asymmetric dimethylarginine in human plasma. Clin Chem. 2005. 1:1268Y71.
  • Singh R, Hattersley A, Harries L. 2007. Reduced peripheral blood mitochondrial DNA content is not a risk factor for Type 2 diabetes. Diabet Med. 24:784–787.
  • Sonney S, Leipzig J, Lott MT, Zhang S, Procaccio V, Wallace DC, Sondheimer N. 2017. Predicting the pathogenicity of novel variants in mitochondrial tRNA with MitoTIP. PLoS Comput Biol. 13:e1005867.
  • Tuppen HA, Blakely EL, Turnbull DM, Taylor RW. 2010. Mitochondrial DNA mutations and human disease. Biochim Biophys Acta. 1797:113–128.
  • van der Walt EM, Smuts I, Taylor RW, Elson JL, Turnbull DM, Louw R, van der Westhuizen FH. 2012. Characterization of mtDNA variation in a cohort of South African paediatric patients with mitochondrial disease. J Hum Genet. 20:650–656.
  • Venter M, Malan L, van Dyk E, Elson JL, van der Westhuizen FH. 2017. Using MutPred derived mtDNA load scores to evaluate mtDNA variation in hypertension and diabetes in a two-population cohort: the SABPA study. J Genet Genom. 44:139–149.
  • Venter M, van der Westhuizen FH, Elson JL. 2018. The aetiology of cardiovascular disease: a role for mitochondrial DNA?. Cardiovasc J Afr. 28 (doi: 10.5830/CVJA-2017-037) 29:122–132.
  • Wajant H, Pfizenmaier K, Scheurich P. 2003. Tumor necrosis factor signaling. Cell Death Differ. 10:45–65.
  • Weissensteiner H, Pacher D, Kloss-Brandstätter A, Forer L, Specht G, Bandelt H-J, Kronenberg F, Salas A, Schönherr S. 2016. HaploGrep 2: mitochondrial haplogroup classification in the era of high-throughput sequencing. Nucl Acids Res. 44:W58–W63.
  • World Medical Association. 2004. World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. J Int Bioethique. 15:124-129.
  • Wu L, Chiou C, Chang P, Wu J. 2004. Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta. 339:1–9.
  • Yu E, Calvert PA, Mercer JR, Harrison J, Baker L, Figg NL, Kumar S, Wang JC, Hurst LA, Obaid DR, et al. 2013. Mitochondrial DNA damage can promote atherosclerosis independently of reactive oxygen species through effects on smooth muscle cells and monocytes and correlates with higher-risk plaques in humans. Circulation. 128:702–712.
  • Zhong Z, Liang S, Sanchez-Lopez E, He F, Shalapour S, Lin X-J, Wong J, Ding S, Seki E, Schnabl B, et al. 2018. New mitochondrial DNA synthesis enables NLRP3 inflammasome activation. Nature. 560:198.
  • Zhou M, Zhu L, Cui X, Feng L, Zhao X, He S, Ping F, Li W, Li Y. 2016. Reduced peripheral blood mtDNA content is associated with impaired glucose‐stimulated islet β cell function in a Chinese population with different degrees of glucose tolerance. Diabetes Metab Res Rev. 32:768–774.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.